Evoke Pharma Research and Development Expenses 2012-2024 | EVOK
Evoke Pharma research and development expenses from 2012 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Evoke Pharma Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$0 |
| 2022 |
$0 |
| 2021 |
$1 |
| 2020 |
$7 |
| 2019 |
$3 |
| 2018 |
$4 |
| 2017 |
$7 |
| 2016 |
$7 |
| 2015 |
$8 |
| 2014 |
$10 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$2 |
Evoke Pharma Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-06-30 |
|
| 2024-03-31 |
$0 |
| 2023-12-31 |
$0 |
| 2023-09-30 |
|
| 2023-06-30 |
$0 |
| 2023-03-31 |
$0 |
| 2022-12-31 |
$0 |
| 2022-09-30 |
$0 |
| 2022-06-30 |
$0 |
| 2022-03-31 |
$0 |
| 2021-12-31 |
$0 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$1 |
| 2019-09-30 |
$1 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$1 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$2 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$2 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$2 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$2 |
| 2016-03-31 |
$2 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$2 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.004B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
